Vijay D Ivaturi (Vijay Ivaturi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Topics

Clinical Decision Support

Positron Emission Tomography

Polycystic Kidney Disease

Human Immunodeficiency Virus

Top Venues

Journal of clinical pharmacology

Nature communications

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis. Kidney360 5 (7) (2024)
Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis. Kidney360 5 (7) (2024)
Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis. Kidney360 5 (7) (2024)
Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-term Efficacy of Tolvaptan in ADPKD: A Post-hoc Analysis. Kidney360 (2024)
Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-term Efficacy of Tolvaptan in ADPKD: A Post-hoc Analysis. Kidney360 (2024)
Benjamin Ribba, Gennaro Pagano, Niklas Korsbo, Vijay D Ivaturi, Antoine Soubret
Artificial Intelligence and Disease Modeling: Focus on Neurological Disorders. Clinical pharmacology and therapeutics (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Vijay D Ivaturi, Jogarao V S Gobburu, Bruce Leslie, Xiaofeng Wang, Pravin Jadhav
Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis. Kidney360 5 (7) (2024)
Benjamin Ribba, Gennaro Pagano, Niklas Korsbo, Vijay D Ivaturi, Antoine Soubret
Artificial Intelligence and Disease Modeling: Focus on Neurological Disorders. Clinical pharmacology and therapeutics 115 (6) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Jogarao V S Gobburu, Vijay D Ivaturi, Xiaofeng Wang, Susan E Shoaf, Pravin Jadhav, Vicente E Torres
Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post-hoc Analysis of TEMPO 3:4. Kidney360 (2023)
Praneeth Jarugula, Ayse Akcan-Arikan, Flor Munoz-Rivas, Brady S Moffett, Vijay D Ivaturi, Danielle Rios
Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 66 (4) (2022)
Praneeth Jarugula, Sarah Scott, Vijay D Ivaturi, Andreas Noack, Brady S Moffett, Adnan Bhutta, Jogarao V S Gobburu
Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. Journal of clinical pharmacology (2022)
Allison Dunn, Brady S Moffett, Vijay D Ivaturi, Jogarao V S Gobburu
Characterization of Drug-Drug Interactions on the Pharmacokinetic Disposition of Busulfan in Pediatric Patients during Hematopoietic Stem Cell Transplantation Conditioning. British journal of clinical pharmacology (2021)
Ahmed M Salem, Tao Niu, Chao Li, Brady S Moffett, Vijay D Ivaturi, Mathangi Gopalakrishnan
Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: a Pharmacokinetic-Pharmacodynamic Modeling Approach. Journal of clinical pharmacology (2021)
Kinjal Sanghavi, Pradeep Vuppala, Vijay D Ivaturi, Lora Hamuro, Amit Roy, Satyendra Suryawanshi
Nivolumab exposure-response analysis for adjuvant treatment of melanoma supporting a change in posology. CPT: pharmacometrics & systems pharmacology 10 (7) (2021)
Hechuan Wang, Janel Long-Boyle, Beth Apsel Winger, Theodore Nicolaides, Sabine Mueller, Michael Prados, Vijay D Ivaturi
Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas. Journal of clinical pharmacology 60 (9) (2020)
Brady S Moffett, Vijay D Ivaturi, Jennifer Morris, Ayse Akcan Arikan, Ankhi Dutta
Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient. Antimicrobial agents and chemotherapy 63 (4) (2019)
Elizabeth W Tucker, Beatriz Guglieri-Lopez, Alvaro A Ordonez, Brittaney Ritchie, Mariah H Klunk, Richa Sharma, Yong S Chang, Julian Sanchez-Bautista, Sarah Frey, Martin A Lodge, Steven P Rowe, Daniel P Holt, Jogarao V S Gobburu, Charles A Peloquin, William B Mathews, Robert F Dannals, Carlos A Pardo-Villamizar, Sujatha Kannan, Vijay D Ivaturi, Sanjay K Jain
Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis. Science translational medicine 10 (470) (2019)
Tao Liu, Tamorah R Lewis, Jason N Moore, Walter K Kraft, Estelle B Gauda, David Sartori, David E Moody, Jogarao V S Gobburu, Vijay D Ivaturi
Could Postnatal Age-Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life? CPT: pharmacometrics & systems pharmacology 8 (7) (2019)
Hechuan Wang, Catherine Sherwin, Jogarao V S Gobburu, Vijay D Ivaturi
Population Pharmacokinetic Modeling of Gentamicin in Pediatrics. Journal of clinical pharmacology 59 (12) (2019)
Hazem E Hassan, Vijay D Ivaturi, Jogarao Gobburu, Thomas P Green
Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets. Clinical and translational science 13 (2) (2019)
Tao Liu, Vijay D Ivaturi, Jogarao V S Gobburu
Integrated Model to Describe Morphine Pharmacokinetics in Humans. Journal of clinical pharmacology 59 (8) (2019)
Vijay D Ivaturi, Mathangi Gopalakrishnan, Jogarao V S Gobburu, Weiyan Zhang, Yongzhen Liu, Christian Heidbreder, Celine M Laffont
Exposure-response analysis after subcutaneous administration of RBP-7000, a once-a-month long-acting Atrigel formulation of risperidone. British journal of clinical pharmacology 83 (7) (2017)
Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Vijay D Ivaturi, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M Zetola, Drew Weissman, Tawanda Gumbo, Gregory P Bisson
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation. British journal of clinical pharmacology 83 (4) (2016)